Recurrent arthritis by Candida glabrata, a diagnostic and therapeutic challenge.

about

Recurrent arthritis by Candida glabrata, a diagnostic and therapeutic challenge.

Item

http://www.wikidata.org/entity/Q42218416

description

2014 nî lūn-bûn

@nan

2014年の論文

@ja

2014年論文

@yue

2014年論文

@zh-hant

2014年論文

@zh-hk

2014年論文

@zh-mo

2014年論文

@zh-tw

2014年论文

@wuu

2014年论文

@zh

2014年论文

@zh-cn

name

Recurrent arthritis by Candida glabrata, a diagnostic and therapeutic challenge.

@en

Recurrent arthritis by Candida glabrata, a diagnostic and therapeutic challenge.

@nl

type

Item

label

Recurrent arthritis by Candida glabrata, a diagnostic and therapeutic challenge.

@en

Recurrent arthritis by Candida glabrata, a diagnostic and therapeutic challenge.

@nl

prefLabel

Recurrent arthritis by Candida glabrata, a diagnostic and therapeutic challenge.

@en

Recurrent arthritis by Candida glabrata, a diagnostic and therapeutic challenge.

@nl

P1476

Recurrent arthritis by Candida glabrata, a diagnostic and therapeutic challenge

@en

P2093

Hasan Afzali

http://www.w3.org/2001/XMLSchema#string

Leila Hosseinpour

http://www.w3.org/2001/XMLSchema#string

Mahzad Erami

http://www.w3.org/2001/XMLSchema#string

Mansoureh Momen Heravi

http://www.w3.org/2001/XMLSchema#string

Somayeh Dolatabadi

http://www.w3.org/2001/XMLSchema#string

P2860

Phenotypic and molecular characterization of Candida nivariensis sp. nov., a possible new opportunistic fungus

Candida bracarensis sp. nov., a novel anamorphic yeast species phenotypically similar to Candida glabrata.

Candida bracarensis detected among isolates of Candida glabrata by peptide nucleic acid fluorescence in situ hybridization: susceptibility data and documentation of presumed infection.

Candida glabrata infection after total hip arthroplasty.

Candida glabrata arthritis: case report and review of the literature of Candida arthritis.

Interpretive breakpoints for fluconazole and Candida revisited: a blueprint for the future of antifungal susceptibility testing

Results obtained with various antifungal susceptibility testing methods do not predict early clinical outcome in patients with cryptococcosis

Antifungal susceptibility testing of isolates from a randomized, multicenter trial of fluconazole versus amphotericin B as treatment of nonneutropenic patients with candidemia. NIAID Mycoses Study Group and the Candidemia Study Group

Candida glabrata periprosthetic infection: a case report and literature review.

Fluconazole susceptibility and genotypic heterogeneity of oral Candida albicans colonies from the patients with cancer receiving chemotherapy in China

P2888

s11046-014-9744-6

P304

291-298

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S11046-014-9744-6

http://www.w3.org/2001/XMLSchema#string

P433

5-6

http://www.w3.org/2001/XMLSchema#string

P478

177

http://www.w3.org/2001/XMLSchema#string

P50

Maryam Moazeni

Ali Rezaei-Matehkolaei

Mohammad Javad Najafzadeh

P577

2014-04-22T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

262572143

http://www.w3.org/2001/XMLSchema#string

P698

24752453

http://www.w3.org/2001/XMLSchema#string

P921

Candida glabrata